Endomorphins and related opioid peptides

Vitamins and Hormones

Volumn 65, Issue , 2002, Pages 257-279

  Okada, Yoshio ^a   Tsuda, Yuko ^a   Bryant, Sharon D ^b   Lazarust, Lawrence H ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ENDOMORPHIN 1; ENDOMORPHIN 2; MU OPIATE RECEPTOR; OLIGOPEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; BRAIN LEVEL; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANALGESICS; ANIMALS; BRAIN CHEMISTRY; HUMANS; OLIGOPEPTIDES; RECEPTORS, OPIOID, MU; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036047501     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0083-6729(02)65067-8     Document Type: Review

References (155)

1. A Alt A Mansour H Akil F Medizihradsky J.R Traynor J.H Woods Stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor J. Pharmacol. Exp. Ther. 286 1998 282 288
2. U Arvidsson M Riedl S Chakarabarti J.H Lee A Nakano H Dado H Loh P.Y Law M.W Wessendorf R Elde Distribution and targeting of a μ-opioid receptor (MOR 1) in brain and spinal cord J. Neurosci. 15 1995 3328 3341
3. Y Azuma P.-L Wang M Shinohara K Ohura Immunomodulation of the neutrophil respiratory burst by endomorphin 1 and 2 Immunol. Lett. 75 2000 55 59
4. A Baron L Shuster B.E Elefterhiou D.W Bailey Opiate receptors in mice: Genetic differences Life Sci. 17 1975 633 640
5. V Brantl C Gramsch F Lottspeich R Mertz K.-H Jaeger A Herz Novel opioid peptides derived from hemoglobin: Hemorphins Eur. J. Pharmacol. 125 1986 309 310
6. S.D Bryant S Salvadori P.S Cooper L.H Lazarus New δ-opioid antagonists as pharmacological probes Trends Pharmcol. Sci. 19 1998 42 46
7. N.T Burford L.M Tolbert W Sadee Specific G protein activation and μ-opioid receptor internalization caused by morphine, DAMGO and endomorphin I Eur. J. Pharmacol. 342 1998 123 126
8. G Cardillo L Gentilucci P Melchiorre S Spampinato Synthesis and biological activity of endomorphin-I analogues containing β-amino acids Bioorg. Med. Chem. Lett. 10 2000 2755 2758
9. K.A Carrigan C.J Nelson D.T Lysle Endomorphin-I induces antinociception without immunomodulatory effects in the rat Psychopharmacology 151 2000 299 305
10. 5]enkephalin on passive avoidance behavior in mice Behav. Neurosci. 99 1985 1120 1127
11. 2]-endomorphin 2 (TAPP) are mediated an L-NAME-sensitive mechanism in the rat J. Cardiovasc. Pharmacol. 33 1999 280 284
12. H.C Champion J.E Zadina A.J Kastin L Hackler L.J Ge P.J Kadowitz The endogenous mu-opioid receptor agonists, endomorphin 1 and 2 have novel hypotensive activity in the rabbit Biochem. Biophys. Res. Commun. 235 1997 567 570
13. H.C Champion J.E Zadina A.J Kastin P.J Kadowitz The endogenous μ-opioid agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed of the rat Life Sci. 61 1997 409 415
14. H.C Champion J.E Zadina A.J Kastin L Hackler L.-J Ge P.J Kadowitz Endomorphin 1 and 2, endogenous ligands for the μ-opioid receptor, decrease cardiac output and total peripheral resistance in the rat Peptides 18 1997 1393 1397
15. H.C Champion T.J Bivalacqua D.E Friedman J.E Zadina A.J Kastin P.J Kadowitz Nitric oxide release mediates vasodilator response to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat Peptides 19 1998 1595 1602
16. H.C Champion J.E Zadina A.J Kastin P.J Kadowitz Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse Peptides 19 1998 925 929
17. H.C Champion T.J Bivalacqua D.G Lambert S.M McWilliams J.E Zadina A.J Kastin P.J Kadowitz Endomorphin 1 and 2, the endogenous μ-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat Life Sci. 63 1998 131 136
18. K.-J Chang A Killian E Hazum J.-K Chang Morphiceptin (NH4-Tyr-Pro-Phe-ProCONH2): A potent and specific agonist for morphine (p) receptors Science 212 1981 75 77
19. C.C Chao G Gekker S Hu W.S Sheng K.B Shark D.F Bu S Archer T.H Bidlak P.K Peterson Kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression Proc. Natl. Acad. Sci. USA 93 1996 8051 8056
20. C.C Chao S Hu K.B Shark W.S Sheng G Gekker P.K Peterson Activation of mu-opioid receptors inhibits microglial cell chemotaxis J. Pharmacol. Exp. Ther 281 1997 998 1004
21. Y Chen A Mestek J Liu J.A Hurley L Yu Molecular cloning and functional expression of a μ-opioid receptor from the rat brain Mol. Pharmacol. 44 1993 8 12
22. S.R Childers Opioid receptor coupled second messenger system Life Sci. 48 1991 1991 2003
23. X.P Chu N.S Xu P Li J.Q Wang Endomorphin-I and endomorphin-2, endogenous ligand for the μ-opioid receptor, inhibit electrical activity of rat rostral ventrolateral medulla neurons in vitro Neuroscience 93 1999 681 686
24. T.J Coderre A.L Vaccarino R Melzack Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection Brain Res. 535 1990 155 158
25. M Connor A Schuller J.E Pintar J Christie MacD μ-Opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B 16/J mice and mutant mice lacking MOR-1 Br. J. Pharmacol. 126 1999 1553 1558
26. A.D Corbett A.I Pareson H.W Kosteritz Opioids I A Herz Handbook of Experimental Pharmacology Vol. 104/1 1993 Springer-Verlag New York 645 675
27. B.M Cox A Goldstein C.H Li Opioid activity of a peptide, β-lipotropin-(61–91), derived from ,β-lipotropin Proc. Natl. Acad. Sci. USA 73 1976 1821 1823
28. M.A Czapla H.C Champion J.E Zadina A.J Kastin L Hackler L.-J Ge P.J Kadowitz Endomorphin 1 and 2, endogenous μ-opioid agonists, decrease systemic arterial pressure in the rat Life Sci. 62 1998 175 179
29. T.K Einstein M.D Hilburger D.M.P Lawrence Immunomodulation by morphine and other opioids H Friedman T.W Klein S Specter Drugs of Abuse, Immunity and Infections 1996 CRC press Boca Raton, FL 103 120
30. 2 (Tyr-W-MIF-1) Peptides 13 1992 623 631
31. C.J Evans D.E Keith Jr. H Morrison K Magendzo R.H Edwards Cloning of a delta opioid receptor by functional expression Science 258 1992 1952 1955
32. A Fischer B.J Undem Naloxone blocks endomorphn-1 but not endomorphin-2 induced inhibition of tachykinergic contractions of guinea pig isolated bronchus Br. J. Pharmacol. 127 1999 605 608
33. H.M Fraser V Chapman A.H Dickenson Spinal local anaesthetic actions on afferent evoked responses and wind-up of nociceptive neurones in the rat spinal cord: Combination with morphine produces marked potentiation of antinociception Pain 49 1992 33 41
34. F.M Freeman I.G Young Identification of the opioid receptors involved in passive-avoidance learning in the day-old chick during the second wave of neuronal activity Brain Res. 854 2000 230 239
35. F.M Freeman S.P.R Rose A.B Scholey Two time windows of anisomycin-induced amnesia for passive-avoidance training in the day-old chick Neurobiol. Learn. Mem. 63 1995 291 295
36. H.E Gendelman A Ghorpade Y Persidsky The neuropathogenesis of HIV-1-associated dementia P.K Peterson J.S Remington Defense of the Brain: Current Concepts in the Immunopathogenesis and Clinical Aspects of CNS Infections 1997 Blackwell Malden, MA 290 304
37. G.L Gessa E Paglietti B.P Quarantotti Induction of copulatory behavior in sexually inactive rat by naloxone Science 204 1979 203 205
38. C Gianoulakis J.-P de Waele Genetics of alcoholism: Role of the endogenous opioid system Metab. Brain Dis. 9 1994 105 125
39. I.E Goldberg G.C Rossi S.R Letchworth J.P Mathis J Ryan-Moro L Leventhal W Su D Emmel E.A Bolan G.A Pasternak Pharmacological characterization of endomorphin- and endomorphin-2 in mouse brain J. Pharmacol. Exp. Ther 286 1998 1007 1013
40. A Goldstein S Tachibana L.I Lowney M Hunkapiller L Hood Dynorphin (1–13), an extraordinarily potent opioid peptide Proc. Natl. Acad. Sci. USA 76 1979 6666 6670
41. A.G Goldstein W Fischli L.I Lowney M Hunkapilier L Hood Porcine pituitary dynorphin: Complete amino acid sequence of biologically active heptapeptide Proc. Nod. Acad. Sci. USA 78 1981 7219 7223
42. R.R Goodman G.W Pasternak Visualization of mu-1 opiate receptors in rat brain by using a computerized autoradiographic subtraction technique Proc. Nod. Acad. Sci. USA 82 1985 6667 6671
43. L Hackler A.J Kastin J Erchegyi J.E Zadina Isolation of Tyr-W-MIF-1 from bovine hypothalami Neuropeptides 24 1993 159 164
44. L Hackler J.E Zadina L.J Ge A.J Kastin Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex Peptides 18 1997 1635 1639
45. A Hahn D Allescher Effect of endomorphin-1 and endomorphin-2 on the ascending and descending reflex pathway in rat intestine Gastroenterology 114 1998 A795
46. E.F Hahn M Carroll-Buatti G.W Pasternak Irreversible opiate agonists and antagonists: The 14-hydroxydihydromorphinone azines J. Neurosci. 2 1982 572 576
47. S Hao H Ogawa Sevoflurane suppresses behavioral response in the rat formalin test: Combination with intrathecal lidocaine produced profound suppression of the responses Neurosci. Lett. 248 1998 124 126
48. S Hao O Takahata H Iwasaki Isobolographic analysis of interaction between spinal endomorphin-I a newly isolated endogenous opioid peptide, and lidocaine in the rat formalin test Neurosci. Lett. 276 1999 177 180
49. S Hao O Takahata H Iwasaki Intrathecal endomorphin-I produces antinociceptive activities modulated by alpha 2-adrenoceptors in the rat tail flick, tail pressure and formalin test Life Sci. 66 2000 195 204
50. A Herz Opioids II 1993 Springer-Verlag Berlin
51. J.W Holaday Cardiovascular effects of endogenous opiate system Annu. Rev. Pharmacol. Toxicol. 23 1983 541 594
52. S.G Holtzman Effects of narcotic antagonists on fluid intake in the rat Life Sci. 16 1975 1465 1470
53. A Horvath A.J Kastin Isolation of tyrosine-melanocyte-stimulating hormone releaseinhibiting factor 1 from bovine brain tissue J. Biol. Chem. 264 1989 2175 2179
54. 2) in human brain cortex Int. J. Peptide. Protein Res. 36 1990 281 284
55. G Horvath C Szikszay Tomboly G Benedek Antinociceptive effects of intrathecal endomorphin-I and -2 in rats Life Sci. 65 1999 2635 2641
56. K Hosohata T.H Burkey J Alfaro-Lopez E Varga V.J Hruby W.R Roeske H.I Yamamura Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptor Eur. J. Pharmacol. 346 1998 111 114
57. S.Y Hugghins H.C Champion G Cheng P.J Kadowitz J.R Jeter Jr. Vasorelaxant responses to endomorphins, nociception, albuterol, and adrenomedullin in isolated rat aorta Life Sci. 67 2000 471 476
58. J Hughes T.W Smith H.W Kosterlitz L.A Forthergill B.A Morgan H.R Morris Identification of two related pentapeptides from the brain with potent opiate agonist activity Nature 258 1975 577 580
59. J Itoh M Ukai T Kameyama Dynorphin A-(1–13) potently improves the impairment of spontaneous alteration performance induced by the μ-selective opioid receptor agonist DAMGO in mice J. Pharmcol. Exp. Ther 269 1994 15 21
60. I Izquierdo Effect of β-endorphin and naloxone on acquisition, memory, and retrieval of shuttle avoidance and habituation learning in rat Psychopharmacology 69 1980 111 115
61. I Izquierdo C.A Netto Role of β-endorphin in behavioral regulation Ann. N. Y. Acad. Sci. 444 1985 162 177
62. I Izquierdo M.A.M.R De Almeida V.R Emiliano Unlike β-endorphin, dynorphin 1–13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avidance learning in rat Psychopharmacology 87 1985 216 218
63. D.S Jessop G.N Major T.L Coventry S.J Kaye A.J Fulford M.S Harbuz F.M DeBree Novel opioid peptides endomorphin-I and endomorphin-2 are present in mammalian immune tissues J. Neuroimmunol. 106 2000 53 59
64. Y Jiang C.M Klodesky S.L Chang Endomorphin-1 and endomorphin-2 induce the expression of c-FOS immunoreactivity in the rat brain Brain Res. 873 2000 291 296
65. S.X Jin L.G Lei Y Wang D.F Da Z.Q Zhao Endomorphin-1 reduces carrageenaninduced Fos expression in the rat spinal horn Neuropeptides 33 1999 281 284
66. 35S]GTPγS binding by endomorphin 1 and DAMGO in mouse brains Peptides 19 1998 755 758
67. J Kamei N Kawashima Y Kasuya Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice Brain Res. 576 1992 139 142
68. J Kamei Y Ohhashi T Aoki N Kawashima Y Kasuya Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by δ opioid agonists, but not by μ and κ opioid agonists Brain Res. 571 1992 199 203
69. J Kamei N Kawashima Y Kasuya Paradoxical analgesia produced by naloxone in diabetic mice κ attributable to supersensitivity of 3 opioid receptor Brain Res. 592 1992 101 105
70. J Kamei K Zushida M Ohsawa H Nagase The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice Eur. J. Pharmcol. 391 2000 91 96
71. T Kato T Nagatsu T Kimura S Sakakibara Studies on substrate specificity of X-prolyl dipeptidyl-aminopeptidase using new chromogenic substrate X-Y- p -nitroanilides Experientia 15 1978 319 320
72. B.L Kieffer Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides Cell. Mol. Neurobiol. 15 1995 615 635
73. B.L Kieffer K Befort C Gaveriaux-Ruff C.G Hirth The S-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization Proc. Natl. Acad. Sci. USA 89 1992 12048 12052
74. W Kromer Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion Pharmacol. Rev. 40 1988 121 162
75. E.H Kwock N.J Dun Endomorphins decrease heart rate and blood pressure possibly by activating vagal afferents in anesthetized rats Brain Res. 803 1998 204 207
76. L.H Lazarus S.D Bryant P.S Cooper R Guerrini G Balboni S Salvadori Design of 8-opioid peptide antagonists for emerging drug applications Drug Discov. Today 3 1998 284 294
77. J Li E Wilk S Wilk Aminoacylpyrolidine-2-nitriles: Potent and stable inhibitors of dipeptidyl peptidase IV (CD 26) Arch. Biochem. Biophys. 323 1995 148 154
78. Y Liang A Mestek L Yu L.G Carr Cloning and characterization of the promoter region of the mouse μ-opioid receptor gene Brain Res. 679 1995 82 88
79. N Ling R Burgus R Guillemin Isolation, primary structure and synthesis of α-endorphin and γ-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity Proc. Mad. Acad. Sci. USA 73 1976 3042 3046
80. H.H Loh H.C Liu A Cavalli W Yang Y.F Chen L.N Wei Mu opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality Mol. Brain Res. 54 1998 321 326
81. J.A.H Lord A.A Waterfield J Hughes H.W Kosterlitz Endogenous opioid peptides: Multiple agonists and receptors Nature 267 1977 495 499
82. A Mansour H Khachaturian M.E Lewis H Akil S.J Watson Anatomy of CNS opioid receptors Trends Neurosci. 11 1988 308 314
83. A Mansour C.A Fox H Akil S.J Watson Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications Trends Neurosci. 18 1995 22 29
84. W.R Martin C.G Eades J.A Thompson R.E Huppler P.E Gilbert The effect of morphine- and morphine-like drugs in the nondependent and morphine-dependent chronic spinal dog J. Pharmacol. Exp. Ther 197 1976 517 532
85. S Martin-Schild A.A Gerall A.J Kastin J.E Zadina Endomorphin-2 κ an endogenous opioid in primary sensory afferent fibers Peptides 19 1998 1783 1789
86. S Martin-Schild J.E Zadina A.A Gerall S Vigh A.J Kastin Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord Peptides 18 1997 1641 1649
87. H.W Matthes R Maldonado F Simonin O Valverde S Slowe I Kitchen K Befort A Dierich M Le Meur P Dolle E Tzavara J Hanoune B.P Roques B.L Kieffer Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene Nature 383 1996 819 823
88. R Mentlein Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides Regal. Peptides 85 1999 9 24
89. H Mizoguchi M Narita D.E Oji C Suganuma H Nagase I Sora G.R Uhl E.Y Cheng L.F Tseng The it-opioid receptor gene lose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in μ-opioid receptor knockout mice Neuroscience 94 1999 203 207
90. K Monory M.C Bourin M Spetea C Tomboly G Toth H.W Matthes B.L Kieffer J Hanoune A Borsodi Specific activation of the p opioid receptor (MOR) by endomorphin 1 and endomorphin 2 Eur. J. Neurosci. 12 2000 577 584
91. 2 and delta opioid binding in the central nervous system of C57BLJ6BY and CXBK (opioid receptor deficient) mice Brain Res. 360 1985 108 116
92. 35S]GTPγS binding in mouse spinal cord Eur. J. Pharmacol. 351 1998 383 387
93. M Narita H Mizoguchi Sora I Narita Mi G.R Uhl L.F Tseng Absence of G-protein activation by μ-opioid receptor agonists in the spinal cord of μ-opioid receptor knockout mice Br. J. Pharmacol. 126 1999 451 456
94. M Narita H Mizoguchi M Narita N.J Dun B.H Hwang T Endoh T Suzuki H Nagase T Suzuki L.F Tseng G-Protein activation by endomorphins in the mouse priaqueductal gray matter J. Biomed. Sci. 7 2000 221 225
95. I Nevo T Avidor-Reiss R Levy M Bayewitch Z Vogel Acute and chronic activation of the p-opioid receptor with endogenous ligand endomorphin differentially regulates adenyl cyclase isozymes Neural. Pharmacol. 39 2000 364 371
96. S.L Nishimura L.D Rech G.W Pasternak Biochemical characterization of high affinity 3H-opioid binding: Further evidence for mu sites Mol. Pharmacol. 25 1984 29 37
97. H Nishiwaki N Saitoh H Nishio T Takeuchi F Hata Relationship between muscarinic autoinhibition and the inhibitory effect of morphine on acetylcholine release from myenteric plexus of guinea pig ileum Jpn. J. Pharmacol. 77 1998 271 278
98. H Nishiwaki N Saitoh H Nishio T Takeuchi F Hata Relationship between inhibitory effect of endogenous opioid via mu-receptors and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum Jpn. J. Pharmacol. 77 1998 279 286
99. H Nishiwaki N Satoh H Nishio T Takeuchi F Hata Inhibitory effect of endomorphin-I and -2 on acetylcholine release from myenteric plexus of guinea pig ileum Jpn. J. Pharmacol. 78 1998 83 86
100. R.A North Drug receptors and the inhibition of nerve cells Br. J. Pharmacol. 98 1989 13 28
101. th American Peptide Symposium Minneapolis, MN, 1999 1999 273
102. 2, and examination of their opioid receptor binding activities and solution conformation Biochem. Biophys. Res. Commun. 276 2000 7 11
103. J Parada-Turska W.A Turski Excitatory amino acid antagonists and memory: Effects of drugs acting at N-methyl-d-aspartate receptors in learning and memory task Neuropharmacology 29 1990 1111 1116
104. G.W Pasternak P.L Wood Multiple mu opiate receptors Life Sci. 38 1986 1888 1898
105. H.J Patel P Venkatesan J Halfpenny M.H Yacoub A Fox P.J Barnes M.G Belvisi Modulation of acetylcholine release from parasympathetic nerves innervating guinea-pig and human trachea by endomorphin-I and -2 Eur. J. Pharmacol. 374 1999 21 24
106. M.G Paterlini F Avitabile B.G Ostrowski D.M Ferguson P.S Portoghese Stereochemical requirements for receptor recognition of the μ-opioid peptide endomorphin-1 Biophys. J. 78 2000 590 599
107. D Paul K.M Standifer C.E Inturrisi G.W Pasternak Pharmacological characterization of morphine-6β- -glucuronide, a very potent morphine metabolite J. Pharmacol. Exp. Ther 251 1989 477 483
108. A Peter G Toth C Tomboly G Laus Tourwe Liquid chromatographic study of the enzymatic degradation of endomorphins, with identification by electrospray ionization mass spectrometry J. Chromatogr 846 1999 39 48
109. P.K Peterson G Gekker S Hu Morphine amplifies HIV -1 expression in chronically infected promonocytes cocultured with human brain cells J. Neuroimmunol. 50 1994 167 175
110. P.K Peterson G Gekker S Hu J Lokensgard P.S Protoghese C.C Chao Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: Implication of an atypical μ-opioid receptor Neurophannacology 38 1999 273 278
111. J.G Pfaus B.B Gorzalka Opioids and sexual behavior Neurosci. Biobehav. Rev. 11 1987 1 34
112. 2 opioid actions Life Sci. 48 1991 2005 2011
113. C.G Pick R Nejat G.W Pasternak Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains J. Pharmacol. Exp. Ther 265 1993 166 171
114. T.L Pierce M.W Wessendorf Immunocytochemical mapping of endomorphin-2-imunoreactivity in rat brain J. Chem. Neuroanat. 18 2000 181 207
115. T.L Pierce M.D Grahek M.W Wessendorf Immunoreactivity for endomorphin-2 occurs in primary afferents in rat and monkey Neuroreport 9 1998 385 389
116. B.L Podlogar M.G Paterlini D.M Ferguson G.C Leo D.A Demeter F.K Brown A.B Reitz Conformational analysis of the endogenous μ-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling FEBS Lett. 439 1998 13 20
117. H Porzig Pharmacological modulation of voltage dependent calcium channels in intact cells Rev. Physiol. Biochem. Pharmacol. 114 1990 209 262
118. B Przewlocka J Mika D Labuz G Toth R Przewlocki Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats Eur. J. Pharmacol. 367 1999 189 196
119. M.E.A Reith H Sershen C Vadasz A Lajtha Strain differences in opiate receptors in mouse brain Eur J. Pharmacol. 74 1981 377 380
120. H Rigter T.J Hannan R.B Messing J.L Martinez Jr. B.J Vasquez R.A Jensen J Veliquette J.L McGaugh Enkephalins interfere with acquisition of an active avoidance response Life Sci. 26 1979 337 345
121. A.Z Ronai J Timar E Mako E Erdo Z Gyarmati G Toth G Orosz S Furst J.I Szekely Diprotin A, an inhibitor of dipeptidyl aminopeptidase TV (EC 3. 4. 14. 5) produces naloxone-reversible analgesia in rat Life Sci. 64 1999 145 152
122. M Saiah A Borgeat O.H.G Wilder-Smith K Rifat P.M Suter Epidual-morphine-induced pruritus: Propofol versus naloxone Anesth. Analg 78 1994 1110 1113
123. S Sakurada J.E Zadina A.J Kastin S Katsuyama T Fujimura K Murayama M Yuki H Ueda T Sakurada Differential involvement of μ-opioid receptor subtypes in endomorphin-1 and -2-induced antinociception Eur. J. Pharmacol. 372 1999 25 30
124. S Sakurada T Hayashi M Yuhki T Fujimura K Murayama A Yonezawa C Sakurada M Takeshita J.E Zadina A.J Kastin T Sakurada Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methylnaltrexone Brain Res. 881 2000 1 8
125. S Salvadori M Attila G Balboni C Bianchi S.D Bryant O Crescenzi R Guerrini D Picone T Tancredi P.A Temussi L.H Lazarus δ Opioidmimetic antagonists: Prototypes for designing a new generation of ultraselective opioid peptides Mol. Med. 1 1995 678 689
126. R Shane S Wilk R.J Bodnar Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV Brain Res. 815 1999 278 286
127. 35S]GTPγS binding in rat brain: Evidence for partial agonist activity at μ-opioid receptor J. Neurochem. 70 1998 1567 1576
128. R.D Soignier A.L Vaccarino A.M Brennan A.J Kastin J.E Zadina Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice Life Sci. 67 2000 907 912
129. G Sowa G Gekker M.M Lipovsky S Hu C.C Chao T.W Molitor P.K Peterson Inhibition of swine microglial cell phagocytosis of Cryptococcus neoformans by femtomolar concentrations of morphine Biochem. Pharmacol. 53 1997 823 828
130. M Spetea K Monory C Tomboly G Toth E Tzavara S Benyhe J Hanoune A Borsodi In vitro binding and signaling profile of the novel μ opioid receptor agonist endomorphin 2 in rat brain membranes Biochem. Biophys. Res. Commun. 250 1998 720 725
131. R.M Spyer Central nervous mechanisms contributing to cardiovascular control J. Physiol. 474 1994 1 19
132. L Stanasila D Massote B.L Kieffer F Pattus Expression of δ κ and μ human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G protein Eur. J. Biochem. 260 1999 430 438
133. M Sarter G Bodewitz D.N Stephens Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist β-carbolines Psychopharmacology 94 1988 491 495
134. L.S Stone C.A Fairbanks T.M Lauphlin H.O Nguyen T.M Bushy M.W Wessendorf G.L Wikox Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2 Neuroreport 8 1997 3131 3135
135. W.S Stone B Walser S.D Gold P.E Gold Scopolamine- and morphine-induced impairment of spontaneous alteration performance in mice: Reversal with glucose and with cholinergic and adrenergic agonists Behav. Neurosci. 105 1991 264 271
136. A Sugimoto-Watanabe K Kubota K Fujibayashi K Saito Antinociceptive effect and enzymatic degradation of endomorphin-1 in newborn rat spinal cord Int. J. Pharmacol. 81 1999 264 270
137. M.K Sun Pharmacology of reticular spinal vasomotor neurons in cardiovascular regulation Pharmacol. Res. 48 1996 465 494
138. th Japanese Peptide Symposium Kyoto, Japan 2001 Japanese Peptide Society Japan 437 440
139. th European Peptide Symposium Montepellier, France 2001 Editions EDK Paris 753 754
140. D.A Thomas D.L Hammond Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching Brain Res. 695 1995 267 270
141. C Tohda T Yamagichi Y Kuraishi Intracisternal injection of opioid induces itchassociated response through μ-opioid receptors in mice Jpn. J. Pharmacol. 74 1997 77 82
142. M Tonini E Fiori B Balestra V Spelta G D'Agostino A Di Nucci N.C Brecha C Sternini Endomorphin-1 and endomorphin-2 activate μ-opioid receptors in myenteric neurons of the guinea-pig small intestine Naunyn-Schmiedebergs Arch. Pharmacol. 358 1998 686 689
143. L.T Tseng M Narita C Suganuma H Mizogichi M Ohsawa H Nagase J.P Kampine Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in mouse J. Pharmacol. Exp. Ther. 292 2000 576 583
144. 2, a novel dermorphin analog, impairs memory consolidation in mice Eur. J. Pharmacology 239 1993 237 240
145. M Ukai Y Watanabe T Kameyama Effects of endomorphin-1 and -2, endogenous μ-opioid receptor agonists, on spontaneous alteration performance in mice Eur. J. Pharmacol. 395 2000 211 215
146. C.A Williams S.Y Wu S.L Dun E.H Kwok N.J Dun Release of endomorphin-2 like substances from the rat spinal cord Neuosci. Lett. 273 1999 25 28
147. B.L Wolozin G.W Pasternak A classification of multiple morphine and enkephalin binding sites in the central nervous system Proc. Natl. Acad. Sci. USA 78 1981 6181 6185
148. S.Y Wu S.L Dun M.T Wright J.K Chang N.J Dun Endomorphin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons in vitro Neuroscience 89 1999 317 321
149. T Yamaguchi K Kitagawa Y Kuraishi Itch-associated response and antinociception induced by intracisternal endomorphins in mice Jpn. J. Pharmacol. 78 1998 337 343
150. T Yamamoto T.L Yaksh Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, and NMDA antagonist, on the formalin test in the rat Anesthesiology 77 1992 756 763
151. Y.-R Yang T.-H Chiu C.-L Chen Structure-activity relationship of naturally occurring and synthetic opioid tetrapeptides acting on locus coeruleus neurons Eur. J. Pharmacol. 372 1999 229 236
152. K Yasuda K Raynor H Kong C.D Breder J Takeda T Reisine G.I Bell Cloning and functional comparison of κ and δ opioid receptors from mouse brain Proc. Natl. Acad. Sci. USA 90 1993 6736 6740
153. K Yokotani Y Osumi Involvement of μ-receptor in endogenous opioid peptide-mediated inhibition of acetylcholine release from the rat stomach Jpn. J. Pharmacol. 78 1998 93 95
154. J.E Zadina A.J Kastin L.J Ge L Hackler Mu, delta and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments and two potent analogs Life Sci. 55 1994 PL461 PL466
155. J.E Zadina L Hackler L.J Ge A.B Kastin A potent and selective endogenous agonist for the μ-opiate receptor Nature 386 1997 499 502